白癜风中AhR表达下调与IFN-γ产生增加及免疫检查点上调受损相关
该研究检测了186例非节段型白癜风患者和56名匹配对照的外周T细胞AhR表达、血清色氨酸与犬尿氨酸水平及IFN-γ/IL-17A和可溶性检查点分子,发现白癜风患者CD8+ T细胞AhR表达显著降低且与IFN-γ+细胞负相关,AhR激动剂tapinarof可剂量依赖性抑制IFN-γ+ T细胞频率。
要点
- 白癜风患者CD8+ T细胞AhR表达显著降低(P = .003)。
- 活动期患者犬尿氨酸/色氨酸比值高于稳定期(P = .048)。
- tapinarof激活AhR可抑制IFN-γ+ T细胞频率。
核心结论
- 犬尿氨酸-AhR信号通路失调是白癜风中IFN-γ产生增强的驱动因素。
- AhR激动剂有望作为恢复免疫稳态和预防疾病活动的靶向治疗。
研究设计与样本
- 研究纳入186例非节段型白癜风患者和56名匹配对照。
- 检测循环T细胞AhR表达、血清色氨酸和犬尿氨酸水平、细胞内IFN-γ/IL-17A及可溶性检查点分子。
主要发现
- 白癜风患者CD8+ T细胞AhR表达显著降低(P = .003)。
- 活动期患者犬尿氨酸/色氨酸比值高于稳定期(P = .048)。
- CD8+ T细胞低AhR表达与IFN-γ+ CD8+细胞负相关(r = -0.376;P < .001),活动期相关性更强(r = -0.561)。
- AhR表达与PBMC上清中可溶性BTLA、sPD-1和sTIM-3水平正相关。
- tapinarof激活AhR剂量依赖性抑制IFN-γ+ T细胞频率,1 μM时降低55%,3 μM时降低47%(与刺激对照相比,P < .05)。
临床怎么用
- 检测CD8+ T细胞AhR表达和犬尿氨酸/色氨酸比值可能有助于评估白癜风疾病活动度。
- AhR激动剂(如tapinarof)可能作为白癜风靶向治疗选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The kynurenine-aryl hydrocarbon receptor (AhR) axis restrains cytotoxic T-cell activity by tempering IFN-γ release and sustaining immune checkpoint expression, yet its status in vitiligo remains undefined. We profiled AhR expression in circulating T cells, quantified serum tryptophan and kynurenine, and assessed intracellular IFN-γ/IL-17A with soluble checkpoint molecules in 186 patients with nonsegmental vitiligo and 56 matched controls. Patients with vitiligo showed significantly reduced AhR expression in CD8+ T cells (P = .003) and a higher kynurenine/tryptophan ratio in active than in stable disease (P = .048). Low AhR expression in CD8+ T cells correlated inversely with IFN-γ-producing CD8+ cells (r = -0.376; P < .001), this correlation being stronger in active disease (r = -0.561). AhR expression positively correlated with soluble BTLA, soluble PD-1, and soluble TIM-3 levels in PBMC supernatants from patients with vitiligo. Pharmacologic activation of AhR with tapinarof dose-dependently suppressed IFN-γ+ T-cell frequencies, achieving a 55% reduction at 1 μM and a 47% reduction at 3 μM compared with stimulated controls (P < .05). These data identify disrupted kynurenine-AhR signaling as a driver of enhanced IFN-γ production in vitiligo and point to the potential of AhR agonists as targeted therapies to restore immune homeostasis and prevent disease activity in vitiligo.
引用
- Belpaire A, Demeyer A, Berrevoet D, et al. Downregulated Aryl Hydrocarbon Receptor Expression Is Linked with Increased IFN-γ Production and Impaired Immune Checkpoint Upregulation in Vitiligo. J Invest Dermatol. 2025. PMID: 40816656. doi:10.1016/j.jid.2025.07.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。